Yahoo奇摩 網頁搜尋

搜尋結果

  1. Our Business. Our Business. NIPRO creates new value by integrating four businesses. Medical Device BusinessWith the aim of leading global comprehensive health care company. Pharmaceutical BusinessPharmaceutical manufacturing and material technologies for optimal solutions. Pharma Packaging BusinessOffering high-performance elements of ...

    • 長榮三大法人買賣超1
    • 長榮三大法人買賣超2
    • 長榮三大法人買賣超3
    • 長榮三大法人買賣超4
  2. Our Business. Medical Device Business. Pharmaceutical Business. Pharma Packaging Business. Regenerative Medicine Business. Pharmaceutical manufacturing and material technologies for optimal solutions.

  3. Our Business Medical Device Business. Enzymes. Most NIPRO ENZYMES are isolated from thermophilic organisms and typically offer the following excellent characteristics. These enzymes are widely used for reagents in diagnostics, food analysis, and other applications. Super thermal stability. Superior storage stability. High purity. Applications.

  4. Hospital Products. Proposing new systems for safety and reliability to reduce the load on medical personnel. By making medical devices disposable, the number of incidences of patients being infected has been greatly reduced.

  5. ニプロのIR情報のページです。財務情報、経営方針、IR資料や株式関係の情報などをご覧いただけます。 IR News 2024.06.03 招集ご通知 / 招集ご通知に際しての電子提供措置事項 2024.05.23 決算説明会資料 国内事業戦略 / 国際事業戦略 グローバル経営の推進 / 医薬事業戦略 /

    • 長榮三大法人買賣超1
    • 長榮三大法人買賣超2
    • 長榮三大法人買賣超3
    • 長榮三大法人買賣超4
  6. 2024年3月31日 · This page details NIPRO’s corporate profile. View an overview of NIPRO, its officers, and main offices. COMPANY NAME NIPRO CORPORATION ESTABLISHED JULY 8, 1954 REGISTERED HEAD OFFICE 3-26, Senriokashinmachi, Settsu, Osaka, 566-8510, Japan

  7. Half-type kits. Combination product with a double-ended needle. Faster processing and easier handling than conventional methods. Designed with the inlet on top and IV infusion outlet on the bottom to eliminate the need for multiple needle punctures of the rubber septum, which reduces leakage and coring.

  1. 其他人也搜尋了